Jan Koren
Prague, PR, Czech Republic
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
The journey of patients with diffuse large B-cell lymphoma: from symptoms to diagnosis.
Journal: Leukemia & lymphoma
Published: March 31, 2025
Risk of central nervous system versus systemic relapse in patients with diffuse large B-cell lymphoma treated with R-CHOP: What should we focus on?
Journal: HemaSphere
Published: March 21, 2025
Proton beam therapy for mediastinal Hodgkin lymphoma: A prospective study of clinical efficacy and safety.
Journal: Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology
Published: December 02, 2024
Brentuximab vedotin plus doxorubicin, vinblastine, and dacarbazine in patients with advanced-stage, classical Hodgkin lymphoma: A prespecified subgroup analysis of high-risk patients from the ECHELON-1 study.
Journal: Hematological oncology
Published: September 02, 2020
Outcome of elderly patients with classical Hodgkin's lymphoma.
Journal: Leukemia research
Published: March 31, 2019
Prospective study of brentuximab vedotin in relapsed/refractory Hodgkin lymphoma patients who are not suitable for stem cell transplant or multi-agent chemotherapy.
Journal: British journal of haematology
Published: March 29, 2018
Hodgkin´s Lymhoma - the Treatment Aproaches Development and Current Trends
Journal: Klinicka onkologie : casopis Ceske a Slovenske onkologicke spolecnosti
Published: October 23, 2015
Can Rituximab Improve the Outcome of Patients with Nodular Lymphocyte-Predominant Hodgkin's Lymphoma?
Journal: Acta haematologica
Published: December 23, 2014
Showing 1-9 of 9
Last Updated: 09/26/2026